(Mary Ann Liebert, Inc./Genetic Engineering News) The results of a new clinical trial have shown the safety and efficacy of the interoperable Artificial Pancreas System smartphone app (iAPS), which can interface wirelessly with leading continuous glucose monitors (CGM), insulin pump devices, and decision-making algorithms.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2CMloSC
No comments:
Post a Comment